A Review on the Treatments for Monocular Visual Impairment for the Development of a Visual Aid

  • Authors

    • Nirvenesh Ravindran
    • Hassan Mohamed
  • Monocular, Visual, Impairment, Aid, Amblyopia
  • Amblyopia is the most commonly found monocular visual impairment in the world. This paper presents an initial investigation into developing a visual aid for monocular visual impaired patients. The investigations conducted in this paper include those from direct interviews from consultant ophthalmologist. Investigations include reviewing the principle required to be embedded into the visual aid such as the distance and depth perception. Stereoscopic cameras and algorithms are also further discussed to interlink with the concepts of depth perception. Monocular visual impairment can most of the time be caused by medical conditions like amblyopia or glaucoma, and rarely caused by accidents and external factors. Thus, existing treatments for amblyopia, the effectiveness and challenges of the treatment are also clearly investigated and scrutinized in this paper. Some of the existing treatments include refractive therapy, occlusion therapy, atropine injections, perceptual learning, pharmacological treatment and acupuncture. This study has provided a clear insight into the requirements of developing a visual aid, thus further addressing the challenges faced by the treatments in this impairment.

  • References

    1. [1] A. Te Broman, B. Munoce, and J. Rodriguez, “The impact of Visual Impairment and Eye Disease on Vision-Related Quality of Life in a Mexican American Population,†Clinical and Epidemiologic Research, vol. 43, pp. 3393–3398, 2002.

      [2] Rahi and D. J. S., “Risk, causes and outcomes of visual impairment after loss of vision in the non amblyopic eye: a population-based study,†The Lancet, pp. 597–602, 2002.

      [3] Adams and J. Slopper, “Update on squint and amblyopia,†Journal of the Royal Society of Medicine, pp. 3–6, 2003.

      [4] J. Garcia and C. Luce, “Eyeternus,†Wordpress, 2013. [Online]. Available: https://eyeternus.wordpress.com/category/main-article/. [Accessed: 26-Mar-2018].

      [5] National Institute for Rehabilitation Engineering, “Visual Distance Perception & Depth Perception,†no. C, pp. 1–12, 2004.

      [6] M. X. Repka et al., “Monocular Oral Reading Performance After Amblyopia Treatment in Children,†American Journal of Ophthalmology, vol. 146, no. 6, pp. 942–947, 2008.

      [7] A. Canessa, M. Chessa, A. Gibaldi, S. P. Sabatini, and F. Solari, “Calibrated depth and colour cameras for accurate 3D interaction in a stereoscopic augmented reality environment,†Journal of Visual Communication and Image Representation, vol. 25, no. 1, pp. 227–237, 2014.

      [8] D. Zhang, V. Nourrit, and J. L. de Bougrenet de la Tocnaye, “3D visual comfort assessment by measuring the vertical disparity tolerance,†Displays, vol. 50, pp. 7–13, 2017.

      [9] Q. Jiang, F. Shao, G. Jiang, M. Yu, Z. Peng, and C. Yu, “A depth perception and visual comfort guided computational model for stereoscopic 3D visual saliency,†Signal Processing: Image Communication, vol. 38, pp. 57–69, 2015.

      [10] J. Wang, “Compliance and patching and atropine amblyopia treatments,†Vision Research, vol. 114, pp. 31–40, 2015.

      [11] X. Y. Liu and J. Y. Zhang, “Dichoptic training in adults with amblyopia: Additional stereoacuity gains over monocular training,†Vision Research, 2016.

      [12] “Lazy Eye Games Treatment,†Lazy Eye Games, 2018. [Online]. Available: http://lazyeyegames.com/. [Accessed: 11-Jul-2018].

      [13] J. Atkinson et al., “Two infant vision screening programmes: prediction and prevention of strabismus and amblyopia from photo-and videorefractive screening,†Eye, vol. 10, no. 2, p. 189, 1996.

      [14] V. Kavitha, M. S. Manumali, K. Praveen, and M. M. Heralgi, “Low vision aid-A ray of hope for an irreversible visual loss in the pediatric age group,†Taiwan Journal of Ophthalmology, vol. 5, no. 2, pp. 63–67, 2015.

      [15] A. M. Tjiam et al., “An educational cartoon accelerates amblyopia therapy and improves compliance, especially among children of immigrants,†Ophthalmology, vol. 119, no. 11, pp. 2393–2401, 2012.

      [16] L. Dr. Hsien Han and G. Ramakrishnan, Ophthalmologists Interview. Tun Hussein Eye Hospital, 2018.

      [17] C. A. Kottmeier and J. S. Gravenstein, “The parasympathomimetic activity of atropine and atropine methylbromide,†Anesthesiology, vol. 29, no. 6, pp. 1125–1133, 1968.

      [18] I. Rehman and S. S. Bhimji, “Anatomy, Head, Eye,†in StatPearls [Internet], StatPearls Publishing, 2018.

      [19] G. D. E. Maconachie and I. Gottlob, “The challenges of amblyopia treatment,†Biomedical Journal, vol. 38, no. 6, pp. 510–516, 2015.

      [20] “Neurokinematix,†Cambridge Research Systems, 2018. [Online]. Available: https://www.crsltd.com/news-and-events/news/neurokinematix/. [Accessed: 11-Jul-2018].

      [21] M. Cleary, A. D. Moody, A. Buchanan, H. Stewart, and G. N. Dutton, “Assessment of a computer-based treatment for older amblyopes: the Glasgow Pilot Study,†Eye, vol. 23, no. 1, p. 124, 2009.

      [22] I. Vedamurthy et al., “A dichoptic custom-made action video game as a treatment for adult amblyopia,†Vision research, vol. 114, pp. 173–187, 2015.

      [23] R. Fattal, D. Lischinski, and M. Werman, “Gradient domain high dynamic range compression,†in ACM transactions on graphics (TOG), 2002, vol. 21, no. 3, pp. 249–256.

      [24] C. L. Tomlinson, R. Stowe, S. Patel, C. Rick, R. Gray, and C. E. Clarke, “Systematic review of levodopa dose equivalency reporting in Parkinson’s disease,†Movement disorders, vol. 25, no. 15, pp. 2649–2653, 2010.

      [25] F. Stocchi et al., “Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDEâ€PD study,†Annals of neurology, vol. 68, no. 1, pp. 18–27, 2010.

      [26] J. M. Helms, “Acupuncture energetics,†Berkeley: Medical Acupuncture Publishers, pp. 444–447, 1995.

      [27] D. S. C. Lam et al., “Adjunctive effect of acupuncture to refractive correction on anisometropic amblyopia: one-year results of a randomized crossover trial,†Ophthalmology, vol. 118, no. 8, pp. 1501–1511, 2011.

      [28] A. Au, “Visual disability,†Acupunture.com.au, 2006. [Online]. Available: http://www.acupuncture.com.au/articles/article14.html. [Accessed: 23-Jun-2018].

  • Downloads

  • How to Cite

    Ravindran, N., & Mohamed, H. (2018). A Review on the Treatments for Monocular Visual Impairment for the Development of a Visual Aid. International Journal of Engineering & Technology, 7(4.35), 282-285. https://doi.org/10.14419/ijet.v7i4.35.22747